LIfT BioSciences

Drug Discovery

Membership category
Corporate

Translation & Innovation Hub, Imperial College White City Campus, 80 Wood Lane, London, W12 0BZ, United Kingdom

LIfT BioSciences at a glance

LIfT BioSciences is London based biotech bringing first-in-class Neutrophil Based Cell therapy to treat patients with solid tumours.

About LIfT BioSciences

LIfT is the only biotech company in the world with a Neutrophil Based Cell Therapy Platform (N-LIfT). The N-LIfT platform is flexible & unique which enables us to produce different types of Immuno-Modulatory Alpha Neutrophils (IMANs) for a wide range of different purposes. Different IMANs can be developed to treat cancers, auto-immune diseases, neurological conditions and anti-microbial resistance. LIfT has six comprehensive worldwide patents across sourcing, selecting and producing Immunomodulatory Alpha Neutrophils from both HSCs and iPSCs, and covering their product composition. As such, we own the worldwide right to produce neutrophils or myeloid progenitors from healthy donors with cancer killing ability.

Therapeutic area(s)

Articles LIfT BioSciences has contributed to